Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans (original) (raw)

Clinical Oncology/Epidemiology

British Journal of Cancer volume 67, pages 358–361 (1993)Cite this article

Abstract

Estraumustine phosphate (EMP), a cytotoxic drug used in the treatment of prostatic carcinoma, has been shown to exert cytotoxic effects on glioma cells in vitro. The drug uptake is assumed to depend on a specific estramustine binding protein (EMBP). One of the main difficulties in achieving cytotoxic effect in malignant brain tumours is believed to be due to the poor penetration of cytotoxic drugs into tumour tissue. In patients with malignant supratentorial brain tumours we have analysed the uptake of EMP metabolites in tumour tissue after oral administration and demonstrated EMBP in the same tissue specimens. Sixteen patients were given 280 mg EMP orally 14 h prior to surgery. Specimens from brain tumour tissue, cystic fluid, and serum were collected during surgery. Using gas chromatography the metabolites of EMP, estramustine (EaM) and estromustine (EoM), were quantified, EMBP was demonstrated by immunohistochemistry. The mean concentrations of EaM and EoM, expressed in ng g-1, were 60.3 and 38.4 in tumour tissue and 3.5 and 56.3 in serum, respectively. An accumulation of EaM in tumour tissue was found with a mean concentration gradient of 16.1 versus serum, while the gradient for EoM was 0.76. EMBP was demonstrated with a high degree of staining in all but one tumour. The high concentrations of EaM and EoM found in malignant brain tumour tissue correspond to potentially cytotoxic levels. The present results as well as the earlier in vitro demonstrated cytotoxic effects on glioma cells strengthen the possibility of a therapeutic effect of EMP in the treatment of malignant brain tumours.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 24 print issues and online access

$259.00 per year

only $10.79 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Oncology, University Hospital, Umeå, Sweden
    AT Bergenheim

Authors

  1. AT Bergenheim
    You can also search for this author inPubMed Google Scholar
  2. K Edman
    You can also search for this author inPubMed Google Scholar
  3. E von Schoultz
    You can also search for this author inPubMed Google Scholar
  4. MI Hariz
    You can also search for this author inPubMed Google Scholar
  5. R Henriksson
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Bergenheim, A., Gunnarsson, P., Edman, K. et al. Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans.Br J Cancer 67, 358–361 (1993). https://doi.org/10.1038/bjc.1993.65

Download citation